Insiders Eyenovia, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 11:59:58 2024-04-30 am EDT			5-day change	1st Jan Change
0.782 ^USD	+9.80%		+45.60%	-62.02%

Apr. 25	Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi and Clobetasol Propionate Ophthalmic Suspension	CI
Apr. 08	Eyenovia to Weigh Potential Sale, Other Strategic Alternatives	MT

Eyenovia, Inc. Appoints Michael Geltzeiler to Serve on the Board and as the Chair of the Audit Committee of the Board	Nov. 09	CI
Insider Buy: Eyenovia	23-08-17	MT
Insider Sell: Eyenovia	23-05-03	MT
Insider Sell: Eyenovia	23-05-01	MT
Insider Sell: Eyenovia	23-04-17	MT
Eyenovia Announces Independent Director Stephen Benjamin to Step Down to Assume Role of Head of White House’s Office of Public Engagement	23-02-28	CI
Eyenovia Promotes Bren Kern to COO	22-12-08	MT
Eyenovia, Inc. Announces Promotion of Bren Kern to Chief Operating Officer and Corporate Vice President, Effective January 1, 2023 and Julia Haller Steps Down from its Board of Directors	22-12-08	CI
Eyenovia, Inc. Announces Retirement of Ken Lee as Lead Independent Director	22-09-30	CI
Eyenovia Names Operations Chief Michael Rowe as CEO	22-07-27	MT
Eyenovia, Inc. Announces Board Changes	22-07-27	CI
Eyenovia, Inc. Announces CEO Changes	22-07-27	CI
Eyenovia Appoints Bren Kern as SVP of Manufacturing and Operations	22-07-18	CI
Eyenovia, Inc. Announces Executive Changes	22-07-07	CI
Insider Buy: Eyenovia	22-06-23	MT
Eyenovia Says Chief Executive Sean Ianchulev to Step Down	22-06-07	MT
Eyenovia Inc. Announces Transition of Sean Ianchulev from CEO to Non-Executive Chairman of the Board	22-06-07	CI
Eyenovia, Inc. Announces Resignation of Sean Ianchulev as Chief Executive Officer	22-06-07	CI
Insider Buy: Eyenovia	22-05-12	MT
Insider Buy: Eyenovia	22-04-25	MT

No results for this search